Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

The yen plummeted, triggering a new round of crisis? Oil prices soaring may dismantle arbitrage trading, posing a risk of "water withdrawal" for $1.2 trillion in U.S. bonds.

Halk Island is attacked! Trump launches an "attack to promote peace" offensive, global oil lifeline sounds the alarm again.

Microsoft Corporation (MSFT.US) Azure takes the lead and becomes the first global cloud service provider to begin validating the NVIDIA Corporation Vera Rubin NVL72 system.
The yen plummeted, triggering a new round of crisis? Oil prices soaring may dismantle arbitrage trading, posing a risk of "water withdrawal" for $1.2 trillion in U.S. bonds.

Halk Island is attacked! Trump launches an "attack to promote peace" offensive, global oil lifeline sounds the alarm again.

Microsoft Corporation (MSFT.US) Azure takes the lead and becomes the first global cloud service provider to begin validating the NVIDIA Corporation Vera Rubin NVL72 system.

RECOMMEND

“A+H” Team Continues To Expand Hard Technology Firms Accelerate Global Deployment
11/03/2026

Anti‑Stagflation Theme Guides Hong Kong Allocation Institutions Identify Power And Energy Assets As Short‑Term Core
11/03/2026

U.S. Equities Enter “Always‑On” Trading Era Nasdaq Advances Stock Tokenization Framework
11/03/2026


